Nausea and Vomiting Archives

Eagle Announces Acquisition of Acacia in Strategic Good Fit

Acquisitions, Atrial Fibrillation, Business, Chemotherapy, Generics, Hospital Products, Postoperative Nausea and Vomiting (PONV), Shareholders, Therapeutics, Ventricular Tachycardia

New Jersey-based Eagle Pharmaceuticals, a company geared towards pharmaceutical hospital sales, finalized terms to acquire Acacia Pharma.

Cosette Pharmaceuticals Launches First Injectable Product – Prochlorperazine Edisylate Injection in the U.S.

Brand Launches, Business, Daiichi Sankyo, Injectables, IQVIA, Issue Archives, Nausea and Vomiting, Pharma Companies, R&D, Schizophrenia, Therapeutics

Cosette Pharmaceuticals Inc., a New Jersey-based pharmaceutical company, announced the launch of Prochlorperazine Edisylate injection, 10 mg/2ml (5mg/ml).

FDA Approves Acacia Pharma’s Barhemsys for PONV

Approvals, Business, Complete Response Letter, FDA, FDA/Regulatory, New Drug Application (NDA), Postoperative Nausea and Vomiting (PONV), Shares, Stocks

Shares of Acacia Pharma skyrocketed in trading after the company announced FDA approval for Barhemsys (amisulpride injection) for the prevention and treatment of postoperative nausea and vomiting (PONV) in adults.